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Summary.-Anti-NSA3 antiserum was found to react with many kinds of benign
and malignant tumours, as well as foetal skin and intestinal extracts. The corres-
ponding antigens isolated from nervous tissue, benign breast adenoma, and a fibro-
sarcoma were compared. Immunoprecipitation cannot distinguish between these
antigens, and their amino-acid contents were comparable. However, immuno-
absorption identified an antigenic determinant that was confined to nervous tissue.
Indirect immunofluorescence further confirmed the validity of the concept of a
nervous form vs a mesenchymal form of the antigen. Furthermore, immunofluores-
cence enabled the localization of the antigen found in non-nervous tissue to mesen-
chyme (mesenchyme-associated antigen: MAA), whether the mesenchymal tissue
be normal (foetal organs), tumoral (fibrosarcoma) or reactional (connective-tissue
stroma of epithelial tumours).
WE HAVE RECENTLY reported the
characterization and localization of a
glycoprotein (NSA3) associated with the
nervous system (Delpech et al., 1976a).
This glycoprotein was found to be com-
parable to the "brain-specific 02 glyco-
protein" of Warecka & Bauer (1967).
Exchange ofantisera and purified antigens
between the laboratories allowed the iden-
tification ofthe 2 antigens. The systematic
search for the antigen in tumours led to
our discovery of its presence in non-
nervous tumours (Delpech et al., 1976b).
This discovery, in conjunction with the
observation that cancer patients' lympho-
cytes could be sensitized to an antigen in
the normal nervous system (Field &
Caspary, 1970), led us to attempt to eluci-
date the immunochemical and immuno-
histological characteristics of the antigen
foun'd in non-nervous tumours. We show
here that this component, which is anti-
genically close to NSA3, is a glycoprotein
which is associated with foetal and tumour
mesenchyme (mesenchyme-associated
antigen or MAA).
MATERIAL AND METHODS
Tumours and organs.-The tumours are
listed in Table I. They were obtained by
surgery. When practicable, the tumours were
divided into 3 parts: one for histological
study, another for immunofluorescence study,
and the third for immunochemical study.
Apparently normal organs, also listed in
Table I, were obtained during necropsy per-
formed less than 6 h after death. Organ and
tumour extracts were obtained by grinding
the tissues in PBS (NaCl 8 g/l with OO1M
phosphate at pH 7.4) with an Ultra-Turrax.
The mixture was centrifuged for 10 min at
32,000 g. The supernatants were collected,
dialysed against deionized water and lyophil-
ized. Foetuses were obtained from spon-
taneous abortions at 3-4 months' gestation.
Organs were extracted as described above.
Lyophilized samples were reintroduced into
PBS in concentrations of 50 or 100 mg/ml.
The portion that remained insoluble after
centrifugation at 12,000 g was discarded. The
proteins in the supernatant were assayed by
the Lowry technique.
Fibroblast culture.-Granuloma fibroblasts
were cultured in RPMI (Eurobio) containing
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atmosphere. The antigen was sought after
sonication of a 0Iml pellet reintroduced into
0-1 ml PBS, and in the culture medium after
2 days' growth in the absence offoetal serum.
Fibroblasts were also cultured on glass slides
and acetone-fixed at -20°C for immuno-
fluorescence studies.
Purification of antigens.-NSA3 was pre-
pared in 2 steps. First, cerebral extract was
reintroduced into PBS (50 mg/ml) and sub-
mitted to 6B Sepharose chromatography
(Delpech et al., 1976). The initial peaks from 3
chromatographic runs were pooled and
dialysed against 5 1 of 01M phosphate buffer
(pH 5). After centrifugation, the insoluble
portion was discarded and the supernatant
was neutralized with NaOH to a final pH of7.
This adjusted supernatant was incubated for
48 h at room temperature with the anti-liver
serum polymer (1 g of moist polymer to 1 mg
of protein), the polymer was rinsed with
PBS, and the antigen precipitated out from
the effluent with 50%-saturated ammonium
sulphate. This precipitate was reintroduced
into deionized water, dialysed against de-
ionized water and lyophilized. In the second
step, rabbits were inoculated with this antigen
(see below). The antiserum obtained was
absorbed out with liver extract and poly-
merized. This polymer was used to isolate the
cerebral antigen from the fraction of crude
brain extract soluble at pH 5 (3-4 mg of
proteins/g of moist polymer). After 48h incu-
bation at room temperature, the polymer was
washed in PBS until the optical density
reached 0 05 at 280 nm. The polymer was
then packed in a 60ml syringe and treated
with pH 2-8 glycerine-HCI buffer at a flow
rate of 5-10 ml/h. Protein elution was con-
tinuously registered. The eluate was dialysed
against deionized water, then against twice
distilled water (100 volumes) and lyophilized.
The same method was used to obtain NSA3
from the fibrosarcoma-absorbed polymerized
anti-NSA3 serum (Polymer No. 2; see below).
Mesenchymal antigen was similarly pre-
pared from a fibrosarcoma and from a breast
adenoma with No. 1 anti-NSA3 polymer. The
preparations obtained with 60 g of polymer
incubated with 200 mg of proteins weighed
from 0 5 to 1 mg. The purity ofthese prepara-
tions was evaluated by double immuno-
diffusion, acrylamide-agarose chromato-
graphy and inoculation into rabbits.
Human skin collagen was isolated by the
technique of Rothbard & Watson (1972).
Collagen was extracted from skin with 0.5%
acetic acid, precipitated at pH 7*3, washed in
deionized water, and lyophilized.
Antisera.-Antisera were prepared in rab-
bits against organ extracts (brain, liver) and
purified antigens (NSA3, fibrosarcoma MAA
and breast adenoma MAA). The antigenic
preparation (50 mg of lyophilized organ ex-
tract or 1 mg of purified antigen) was intro-
duced into 0 5 ml of PBS, emulsified in
0 5 ml of Freund's complete adjuvant, and
then injected s.c. Starting at the 4th week
after injection, the injections were repeated
weeklyuntil thedesired activity was achieved.
Once a week the rabbits were bled from the
ear vein.
In order to be certain of our sera's specific
reactivity (anti-NSA3 or anti-MAA), steps
were always taken to eliminate any anti-
bodies directed against non-organ-specific
antigens. Antisera were absorbed with 50 mg
of plasma proteins and 50-100 mg of hepatic
extract per ml. After 24 h at room tempera-
ture, the preparation was centrifuged (12,000
g for 10 min) and stored at -30°C. This pro-
duct was used for the rapid study by immuno-
diffusion of the antiserum activity. The
specific antiserum used eitherforthe immuno-
fluorescent studies or for the antigen estima-
tion was cleared of common antibodies on a
mixed plasma/organ extract polymer. The
antiserum was incubated with 1 g/ml ofmoist
polymer for 48 h at room temperature. The
polymer was then washed with PBS until the
optical density reached 0 05 at 280 nm. After
precipitation in 40% saturated ammonium
sulphate, the gamma globulins were washed
once and reintroduced into a PBS volume
equal to half the initial volume and dialysed
against PBS. Aliquots (0-5 ml) were collected
and stored at -76°C. The quality of the
purified anti-NSA3 was verified by double
immunodiffusion against lyophilized cerebral,
hepatic and splenic extract reintroduced into
PBS at a concentration of 50 mg/ml, and
serially diluted to a final dilution of 1: 32. On
staining, no precipitation line was noted with
either liver extract or spleen extract. The
brain extract yielded a single precipitation
line identical to that obtained with Dr
Warecka's brain-specific 02 glycoprotein.
Other antigens and antisera.-Alpha-foeto-
protein and antiserum were purchased from
Institut Pasteur, Paris. Carcinoembryonic
antigen (CEA), normal cross-reacting antigen
(NCA) and their specific antisera were aTUMOUR ANTIGEN CROSS-REACTING WITH NSA3
generous gift from Dr Burtin (Villejuif).
Alpha-2 H globulin and antiserum were
kindly provided by Dr Buffe (Villejuif). Anti-
P2 microglobulin from urine and anti-
serum were kindly given by Dr Lebreton
(Bois Guillaume). Lactoferrin was prepared
from human milk following the method of
Johansson (1969). Glial fibrillary acidic pro-
tein (GFA) and antiserum were prepared as
described earlier (Delpech et al., 1978). Anti-
fibronectin antiserum was obtained from
Behring Institut.
Immunosorbents.-Polymers were prepared
with glutaraldehyde and regenerated accord-
ing to the method described by Avrameas &
Ternynck (1969). Mixed human plasma and
organ polymer were prepared from a mixture
consisting of 3 parts plasma to 1 part each of
liver, spleen and kidney extracts. Each tissue
extract was reintroduced into PBS (50 mg of
lyophilized extract/ml) and centrifuged.
Anti-liver serum was polvmerized without
prior absorption. Two anti-NSA3 immuno-
sorbents were prepared: Polymer 1 (poly-
merized monospecific liver-absorbed anti-
serum) and Polymer 2 (the antiserum which
was previously absorbed with liver extract
(i.e. as 1) was further absorbed with fibro-
sarcoma extract, and then polymerized).
Before polymerization the serum was tested
and found not to react with mesenchymal
tissue and tumours by immunoprecipitation
or immunofluorescence, but to be still reactive
with brain antigen by immunofluorescence.
This Polymer 2 was controlled and found to
have no binding activity to adenoma and
fibrosarcoma extracts under the conditions
described. All of these polymers were treated
at pH 2-8 and used 10 times with no appreci-
able loss of activity. Before incubation with
extracts, they were put into a syringe and
pressure was applied to remove excess water.
Immunological methods.-Immunodiffusion
was performed on agarose gels (1-5%) con-
taining PBS. Holes 3 or 7 mm in diameter
were cut. The diffusion was allowed to pro-
ceed for 48 h at room temperature. The gels
were washed for 3 days in PBS. Slides were
then dried and subsequently stained with
Coomassie Blue, Schiff's reagent or Sudan
Black.
Electrosyneresis (Bussard, 1959) was used
under the conditions previously described
(Delpech et al., 1976b) to detect NSA3 in
column effluents without any concentration.
The sensitivity threshold was about 1 u/ml.
Antigen assay by precipitation inhibition:
We used this technique rather than direct
immunodiffusion in antibody-containing gel,
because the latter is influenced by the degree
of aggregation of proteins, leading to an
underestimation of highly polymerized anti-
gens. In addition, inhibition procedures are
known to be more sensitive. We therefore
assayed the antigens by the precipitation-
inhibition technique. Monoradial reverse
immunodiffusion was used for antibody assay
(Vaerman et al., 1969) which, by measuring
the inhibition of the corresponding antibody,
permits the assay of the antigen concentra-
tion of a given extract. A 2% solution of
agarose in PBS at 56°C was added to an equal
volume of either cerebral extract (2 mg/ml)
or purified NSA3 (0.1 mg/ml). This mixture
was poured into a glass slide supported by a
horizontal surface. After solidification, 3mm
diameter wells were cut into the gel and filled
with the antiserum to be studied. At the end
of 2 days' diffusion in a humid environment,
the slides were washed in PBS, dried, and
stained as described above. Precipitation ring
diameters were measured with a graduated
eye piece. Antigen assay was carried out in
the following way: 30 ,ul of the extract to be
studied containing 0 6-1 mg of proteins was
removed with a Pipetman pipette (Gilson)
and added to 30 ,l of monospecific anti-
serum. After standing for 24 h at room
temperature, the mixture was centrifuged
(3000 g for 15 min) and the supernatant
deposited in the well. ,All assays were per-
formed in duplicate. The reference antiserum
was assigned a value of 100% (30 ,u of PBS
was added to obtain the reference antiserum).
After an efficient absorption, antisera gave a
smaller ring or none at all. Antigen units
were calculated according to the following
formula:
S 100-S inhib. units = - -- -- - X 100
Where S 100 =surface obtained with the
reference antiserum, and S inhib. = surface
obtained after incubation witlh extract.
Based on 15 determinations, the significant
threshold was calculated to be 12 units
(P = 0.05).
Indirect immunofluorescence reaction.-
Cubic fragments whose sides measured -5
mm were fixed in liquid N2 and stored at
-80°C. The fragments were cut in a cryostat
at -20°C. The sections were fixed in alcohol
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for 20 min at 40C. Before use the sections
were rehydrated with PBS for 5 min. The
sections were incubated in a humidified box
at 37°C for 40 min -with 1: 5 and 1:10 diluted
antiserum. Sections were then washed with
PBS x 3 at room temperature. Subsequenitly,
fluorescent sheep anti-rabbitglobulin (Institut
Pasteur, Paris) was applied at a dilution of
1: 20 for 30 min at room temperature. After-
wards, the sections were w-ashed x 3 or x 5
with PBS and mounted with buffered gly-
cerin. Counterstaining -was performed w-%ith
Evans Blue. The controls consisted of non-
immunized rabbit serum, ani antiserum of
another specificity reacting -with NSA2
(Delpech & Delpech, 1975) and the specific
anti-NSA3 serum absorbed out ws%ith the
purified antigen. In order to compare the
cerebral antigen with tumour and foetal
organ antigens, the diluted antiserum (1: 10)
was absorbed out -with extracts the antigenic
concentrations of which had been determined
previously (Table 11). Then the antiserum
was tested on brain sections, foetal skin
sections, breast-adenoma sections. and fibro-
sarcoma sections.
Physico-cheinical methods. Chromato-
graphy was performed on 6B Sepharose
(Pharmacia) or Ultrogel (AcA 34. Industrie
Biologique Fran9aise) in PBS or in Tris-HCl
0-IM pH8 buffer at room temperature. The
flow rate was 8 ml/h. A column was cali-
brated -with Blue Dextran and the Combithek
system (Boehringer). Periodate oxidation
was carried out as follows: 40 jul of 30-60mg/
mnl extracts -were supplemented by 10 Mul of a
0-25M pH6 periodate solution, and incubated
for 48 h at 4°C in the dark.
Enzyme action on antigens: antigen-con-
taining extracts, either from foetal organs or
from tumours, were treated with collagenase
and elastase (Worthington) under conditions
described in the Worthington EnzymeManual
(Freehold, N.J. 1972). These enzymes were
used at the concentration of 2 u/mg protein
for collagenase, and 1 u/mg protein for
elastase. Their activities w%ere verified on 5mg
samples of collagen and elastin. Trypsin
(Industrie Biologique Fran9aise) was used at
a concentration of 250 u/mg protein in pH8
Tris buffer containing O-O1M CaC12. After a
48h incubation at 37°C, the trypsin was
inactivated by di-isopropylfluorophosphate.
Amino-acid analysis: samples were hydro-
lysed in 6N HCI at 110()C for 24 hi under N2.
Amino-acid compositions were determined
using a Durrumn D 500 amino-acid analyser.
RESULTS
Antiyen assay and characterization
Absorbed anti-NSA3 serum gave only
one precipitation line, either with crude
brain extract or purified NSA3. This line
was stainable by Coomassie Blue and
Schiff's reagent, but not by Sudan Black.
WVith the exception of skin extracts,
normal adult organ extracts did not pre-
cipitate with this antiserum, as previously
reported. Relatively large amounts of
antigen were found in foetal skin and
Fra. 1.-Antigen in tumoturs an(l organs. CentrIe well: anti-NSA3 serum. I, braini extract (50 mg/ml).
Other extracts at 100 mg/mi. 2. Hepatoma. '3 ani(l 6, Fibrosarcornas. 4, Normal liver. 5, Gastric
carcinioma. 7, Foetal skill.TUMOUR ANTIGEN CROSS-REACTING WITH NSA3
TABLE I.-Semi-quantitative anti
in normal organs and in tumoug
below significance threshold are i
Foetal organis (1*)
brain
skini
intestinie
ki(lney
spleen
liver
thymus
Adult organs (1)
brain
skin (breast)
int,estine
ki(dney
spleen
liver
Breast carcinomas (10)
Breast a(lenomas (3)
Hepatomas (2)
Kidney carcinomas (2)
Gastric car cinomas (3)
(olonic carcinomas
Rectal carcinomas (2)
Ovary carcinomas (3)
IUteruLs fibroma
Fibr osarcomas (3)
Units/
ml
60
6()
60
0
0
0
200
15
0
40
(I ) 60
45
40
(10)
60
50
40
15
35
30
15.F
90
50
30
40
70
70
25
20
20
25
40
55
(10()
20
70
55
60
60
ND, not (lonie; IF, immunofluorescence
of saml)les. § Strictly locatedl to papilla.
foetal intestine, as well as in foet
Other foetal organs gave a negati
The same antigen was also four
tracts of many tumours. No
difference was observed betwee
9
assay foetal organ antigen and tumour antigen
rs aslues with respect to the anti-NSA3 serum in
n brackets Ouchterlony plate (Fig. 1). Foetal and
tumour antigens were also stained by
IF Schiff's reagent. Semi-quantitative assay of NSA3 by precipitation inhibition
showed the highest amounts in adult
brain. Levels in tumours were variable
- (Table I). The antigen was measurable in
ND almost all tumours studied, regardless of
their histological nature: carcinomas, sar-
comas and benign tumours. Negative
results were obtained in only 2/33 tumours
+ assayed: a breast adenocarcinoma and an
ovarian adenocarcinoma.
The antiserum activity was unmodified
Ot by its absorption by adult human skin
+ collagen (10 mg/ml), sonicated fibroblast
extract (109 cells/ml), or lyophilized
serum-free culture medium (200 mg/ml).
+ Immunoprecipitation tests (Figs. 3, 4)
+ demonstrated the separate identities of
+ ANSA3, the tumour antigen and other
41 tumour-associated antigens (a-foeto-pro-
+ tein, CEA, A2H globulin, NCA, /2 micro-
+ globulin, (-FA, lactoferrin andfibronectin).
N+D Sera against either tumour antigen or ND) brain NSA3 gave reactions of identity in
double-diffusion tests against both tumour
71 antigen and NSA3 (Figs. 5, 6). However,
antigen extracted from tumours was much
less immunogenic than brain NSA3. Sera
from only 2/10 rabbits immunized against
adenoma and fibrosarcoma antigens could
be used for immunochemical study. In
these 2 cases, the antibody titre was 1/4
of the anti-NSA3 antibody titre. Further-
+ more, the immune responses were tran-
ND sient, as the anti-MAA antibodies dis-
appeared from the rabbit serum within
+ 2-3 weeks, whereas the anti-NSA3 anti-
+ bodies usually persisted over 3 months
ti Nmber without reimmunization.
Immunoftuorescence
Immunofluorescence studies confirmed
tal brain. the presence and showed the localization
ve result. in non-nervous tumours of an antigen
id in ex- analogous to NSA3. In all positive cases,
antigenic the specific fluorescence found with anti-
n NSA3, NSA3 serum was not reproduced with the
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FIG. 2.-lImmunochemical comparison between MAA and NSA3. 1, Anti-NSA3 serum. 2, Anti-
fibrosarcoma MAA serum. 3, Fibrosarcoma MAA (2 mg/ml) purified on No. 1 Polymer. 4, NSA3
(1 mg/ml) purified on No. 2 Polymer. 5, Adenoma MAA (1 mg/ml) purified on No. 1 Polymer.
6, Brain extract. 7, Fibrosarcoma extract.
control sera. This specific fluorescent
staining waslocalized inthe fibrous stroma
of the carcinomas; the cancer cells them-
selves presented no fluorescence (Fig. 5).
The tumours that gave negative results
with precipitation inhibition gave positive
results with immunofluorescence. Con-
versely, in the fibrosarcoma studies (Fig.
6) theantibodies markedthe cellularregion
in tumours.
In breast adenofibromas, fluorescence
was also seen in the fibrous part of the
tumour, though the fluorescent staining
was too imprecise to determine accurately
FIG. 3.-Absence of reaction of identity
between MAA and fi2-microglobulin, U2H
ferroprotein and fibronectin. 1, Anti-NSA3
serum. 2, Fibrosarcoma extract (100 mg/
ml). 3, Anti- P2-microglobulin serum. 4,
Anti-U2H-globulin antiserum. 5, Anti-
fibronectin serum.
FIG. 4.-Pattern of differences in identity
between NSA3 and CEA, NCA, ax foeto-
protein, GFA and lactoferrin. 1, Anti-NSA3
serum. 2, NSA3 (1 mg/ml). 3, Anti-CEA
serum. 4, CEA (0-25 mg/ml). 5, Anti-NCA
serum. 6, NCA (0-25 mg/ml) 7, Anti-as-
foetoprotein serum. 8, oc-Foetoprotein.
9, Anti-GFA serum. 10, GFA (1 mg/ml).
11, Anti-lactoferrin serum. 12, Lactoferrin
(0-25 mg/ml).
the antigenic localization withintheregion,
i.e. whether in the cytoplasm, the cyto-
plasmic membrane or the intercellular
space. This last hypothesis was supported
by the negative cellular imprints of
strongly positive tumours. In the foetal
skin and intestine samples examined, theTUMOUR ANTIGEN CROSS-REACTING WITH NSA3
FIG. 5. Breast adenocarcinoma. a, Classical histology. b, Immunofluorescence on an adjacent
section. Carcinous glands are not labelled. Staining occurs in the fibrous stroma reaction mainly between the cells (x 320).
r IG. o.-rlbrosarcoma. a, Ulassical histology. b, lmmunofluorescent labelling by the anti-NSA3
serum. The fibrillary pattern suggests an association with the collagen fibres (x 180).
antigen was localized in the mesenchyme
in the form of highly fluorescent large
granules. Furthermore, by identical im-
munofluorescent techniques, this same
antigen was also found in very narrowly
defined zones of adult tissues (Delpech
et al., 1978): the lamina propria of the
large intestine, the renal papilla, the intra-
lobular connective tissue of the breast,
the subendothelial layer of the uterus and
the intima ofarteries. In this last case, the
immunofluorescent staining appeared to
be clearly separate from the spontaneous
fluorescence of the elastin. Therefore the
antigen is clearly associated with mesen-
chyme and we have designated it "mesen-
chyme-associated antigen" (MAA). The
cultured fibroblasts, however, were not
labelled by the immunofluorescent anti-
body.
Inhibition tests
Tests were undertaken in an attempt
to distinguish between NSA3 and MAA.
Although they appeared identical in
immunodiffusion experiments (Fig. 2), the
results showed that the mesenchymal
antigen is incapable ofabolishing the anti-
bodies' binding to nervous tissue in
immunofluorescence reactions (Table II)
whereas the same antigen totally abolished
the antibodies' binding with mesenchymal
tissues. This is in agreement with the
fact that anti-NSA3 serum, polymerized
after absorption with fibrosarcoma extract
(Polymer No. 2) still bound NSA3 (Fig.
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TABLE II.-Immunoftuorescence assay of 1:10 diluted anti-NSA3 serum absorbed with
organ or tumour extracts
Anti-NSA3 antibody fixation on:
I A-
Absorption with:
Adult brain
Foetal brain
Foetal skin
Fibrosarcoma
Hepatoma
Brain
mg units Foetal Adult
Foetal Breast
skin adenoma Fibrosarcoma
2 12 0 0 0 0 0
10
50
10
50
10
50
20 0 + 0 0 0
100 0 0 0 0 0
20 + + 0 0 0
100 +a + 0 0 0
20 + + 0 0 0
100 +a + 0 0 0
10 20 + + + + ND
50 100 +a + 0 0 ND
+, fixation of antibody; a, fixation attenuated by comparion with the reaction at a lower absorption dose.
2). This technique allowed the preparation
of pure NSA3. Conversely, our 2 anti-
MAA sera showed no specific antigenic
determinant in mesenchyme. The images
obtained were comparable to those ob-
tained with anti-NSA3 serum. Absorbing
out with brain extract abolished all
activity, as did absorption with adenoma
and fibrosarcoma extracts. Hence, identity
ofNSA3 and MAA cannot be complete.
Physico-chemical properties
The precipitation line was easily stained
by Coomassie Blue andby Schiff'sreagent,
indicating a glycoprotein constitution of
the antigen. The antigens were destroyed
by trypsin, but not by incubation with
periodate or with collagenase and elastase.
Electrophoretic mobilities in agarose
were generally those ofox globulins, though
sometimes faster. In crude extracts, anti-
gens behaved as high-molecular-weight
components thatwerepartlydisaggregated
by lower pH (Delpech et al., 1976a, b).
The amino-acid analysis of NSA3,
adenoma MAA and fibrosarcoma MAA
indicated similar compositions (Table III).
DISCUSSION
An antigen reacting with anti-NSA3
antibodies has been shown to be present
in mesenchyme (undifferentiated connec-
tive tissue), mainly that of foetal organs
TABLE III.-Amino-acid analysis of the 3
purified preparations. Compositions were
calculated as molecules ofeach amino acid
per 1000 molecules, without correction
factors
Amino
acids
ASP
THR
SER
GLU
PRO
GLY
ALA
CYS
VAL
MET
ILEU
LEU
TYR
PHE
HIS
LYS
ARG
NSA3
95
57
68
113
47
127
74
7
62
3
33
88
26
34
26
58
44
Adenoma
MAA
97
59
76
124
37
119
82
15
65
7
33
90
27
37
26
64
40
Fibro-
sarcoma
MAA
107
61
67
131
52
97
84
13
70
6
31
91
18
38
23
65
37
and tumours. We designated it "mesen-
chyme-associated antigen" or MAA.
The first point to be discussed is the
relationship between MAA and NSA3.
The immunochemical and biochemical
similarities between these antigens are
obvious, yet differences do exist:
(1) Absorption of anti-NSA3 serum by
purified MAA or crude tumour extracts
does not remove all anti-NSA3 anti-
bodies, as is shown by immunofluorescence
and by the binding properties ofthe MAA-TUMOUR ANTIGEN CROSS-REACTING WITH NSA3
absorbed anti-NSA3 immunosorbent.
Hence MAA does not carry all the anti-
genic determinants ofNSA3. The converse
was not shown, as anti-MAA sera were
completely absorbed by brain extract.
Yet stronger antisera might give different
results, as the immunogenicity of MAA is
much weaker than that of NSA3, and this
further hinders a complete immuno-
chemical comparison of the 2 antigens.
(2) The ontogenic evolution of NSA3
and MAA is dissimilar. NSA3 is a brain-
differentiation antigen, increasing with
maturation of the nervous system, hence
more abundant in adult than in foetal
brain. On the other hand, MAA concentra-
tion decreases and, except in skin, is much
weaker in adult normal tissues than in
foetal tissues. The second point to be
considered is the nature of the link be-
tween MAA and normal or tumoral mesen-
chyme. By means ofimmune precipitation
and immunofluorescence, no antigenic
difference appears to exist between the
different varieties of MAA (foetal mesen-
chyme antigen, carcinoma stroma antigen,
and fibrosarcoma antigen). During tissue
maturation, the mesenchymal antigen
appears to decrease, if not disappear
altogether. When there is a carcinoma,
MAA increases in parallel with the
reaction ofthe stroma. This is particularly
striking in some cases. In the following
healthy - tissue / corresponding - tumour
pairs, the tumour contains at least 10 times
as much antigen as does the corresponding
healthy tissue: hepatoma/liver, colonic
tumour/normal colon, renal carcinoma/
kidney. Comparison of these results with
the quantitative differences between the
amount of antigen in foetal and adult or-
gans such as skin and intestine suggests
that the antigen possesses an oncofoetal
character. MAA cannot be considered
sensu stricto as an onco-foetal antigen,
since traces are always detected by
immunofluorescence in the soft connective
tissue of normal adult organs. It is, how-
ever, not very different from antigens
described as oncofoetal such as ao-foeto-
protein (Abelev, 1963) or CEA (Gold &
Freedman, 1965). Marking this antigen
permits quantification of the fibrous-
stroma reaction, a parameter that has
so far eluded biochemical measurement.
Morphometric evaluation of this stroma
reaction has been made for breast car-
cinoma (Underwood, 1972), where it was
found to predominate in scirrous car-
cinoma. However, Underwood pointed
out the unusual staining of immature
connective tissue. Gerstl et al. (1974)
studied lung carcinoma with Underwood's
morphometric technique. Although they
found it to be inapplicable to lung cancers,
the authors demonstrated marked differ-
ences between stroma-rich epidermoid
carcinomas and oat-cell carcinomas which
were rather poor in stroma. The method
described in the present paper is of par-
ticularinterest in that it permits the mark-
ing of MAA, thus allowing a biochemical
quantification ofthe immature, connective
stroma reaction in carcinomas. This fact
could be of significance in cancerology,
since the precise nature of the stroma-
tumour relation is poorly understood,
though it has been shown that a com-
ponent of connective tissue, as well as
connective tissue itself, could inhibit
tumour growth (Parshley & Mandl, 1965;
Haddow, 1967). The antigen's association
with mesenchyme accounts for its presence
in fibrosarcomas. In all our cases, the
antigen localized in mesenchyme corres-
ponds to intercellular rather than intra-
cellular deposits. Nevertheless, the antigen
was constantly present in mesenchyme,
and constantly absentinnon-mesenchymal
tissues. In this respect, MAA can be con-
sidered as a fibrous tumour marker for
both benign (breast adenoma), and malig-
nant (fibrosarcoma) fibrous tumours. This
association with mesenchyme, as well as
the fibrillar aspect at times encountered in
microscopy, could be construed as indicat-
ing that the antigen is merely a component
of connective-tissue proteins. Its solubility
in physiologic media, its resistance to
collagenase and elastase, and its lack of
cross-antigenicity, demonstrate that MAA
is neither collagen nor elastin. Therefore,
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MAA is probably a glycoprotein whose
structure is associated with the ground
substance. The amino-acid composition
is comparable to that of many varieties
of these glycoproteins (Anderson, 1976).
The glycoproteins are partially soluble in
physiological media, are associated with
collagen, and are more abundant in the
embryo and foetus than in the adult, as
has been demonstrated in animal studies
(Robert et al., 1976).
NSA3 and MAA must be compared to
CEA and the antigens that cross-react
with CEA (Burtin, 1978). This latter
group of glycoproteins is associated with
human tumours and, in spite of their
strong cross-reaction, are present in dif-
ferent cellular varieties: CEA was found
in macrophages and polymorphs (Burtin
et al., 1975) as well as in cancer cells
(Burtin et al., 1973). Similarly, NSA3 and
MAA, which share a large part of their
antigenic determinants, are present in
different tissues. NSA3 is a nervous-system
antigen, while MAA is present in cancer
and foetal stroma, and in some adult
connective tissues. However, the tissue
localization is completely different from
that of CEA and NCA. Furthermore,
anti-CEA and anti-NCA antibodies do not
react with NSA3 and MAA. Therefore, we
conclude that the NSA3-MAA system is
an antigenic system distinct from the
CEA-NCA system. Other tissue and
tumour-associated antigens should be
compared: xZ H globulin (ferritin) was first
discovered in sera from cancer patients
(Buffe et al., 1970) and is a major com-
ponent of foetal liver (Buffe & Rimbaut
1975). Lactoferrin, which is associated
with polymorphs (Masson, 1970), was also
found in tumours (Loisilier et al., 1971)
including brain tumours (Delpech &
Buffe, 1972). 2 Microglobulin, a urinary
protein (Berggard & Bearn, 1968) and a
component ofthe HLA system, was found
in various human tissues (Governa &
Biguzzi, 1976). Fibronectin, a fibroblast
surface protein (Ruoslahti et al., 1973) was
found to bind to collagen (Engvall &
Ruoslahti, 1977). Glial fibrillary acidic
protein, a specific marker for astrocytes,
was also found in gliomas (Delpech et al.,
1978; Eng & Rubinstein, 1978). Apart
from the histological features described
in the literature, which distinguish these
antigens from MAA and NSA3, the
immunoprecipitation tests showed clearly
that they are not identical to MAA. MAA
can be considered as a new oncofoetal
marker for mesenchymal tissue.
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